In other countries
The same active substances on other registers, the same brand first.
- CosmegenBrazil · Organon Farmacêutica Ltda.Same brand
- CosmegenBrazil · Laboratórios Bagó do Brasil S/ASame brand
- CosmegenBrazil · Prodome Química e Farmacêutica LtdaSame brand
- CosmegenCanada · 0.5 MG / VIAL · Powder For Solution · Recordati Rare Diseases Canada INCSame brand
- CosmegenItaly · Polvere per soluzione iniettabile · Recordati Rare Diseases SarlSame brand
- CosmegenUnited States · 0.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Recordati RareSame brand
- K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vialSingapore · 0.5 mg/vial · injection, powder, for solution · Shoei Universal Corporation Pte LTDSame form
- DactinomycinUnited States · 0.5MG/VIAL · injectable · HikmaSame form
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.
Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Dactinomycin
- Dosage form
- Inj 0.5 mg vial
- Register
- New Zealand (PHARMAC)
- Status
- Funded
- Status in the register
- Funded by PHARMAC
- Procedure
- Community Pharmaceutical Schedule
- Supply
- Funded (PHARMAC)